The impact of COVID-19 pandemic on psoriasis patients, and their immunosuppressive treatment: a cross-sectional multicenter study from Turkey.
Selda Pelin KartalGökçen ÇelikOğuz YılmazEda Öksüm SolakBüşra Demirbağ GülTuba Kevser ÜstünbaşMelis GönülalSevim BaysakEsma İnan YükselBegüm ÜnlüMünevver GüvenAli BozdağGökhan ÇınarSelim KartalMurat BorluMüge Güler ÖzdenBurhan EnginServer SerdaroğluDidem Didar BalcıBilal DoğanDemet ÇiçekAyça Cordan YazıcıSema AytekinNeslihan ŞendurHayriye SarıcaogluNida Gelincik KaçarAsena Cigdem DoğramacıLevent DönmezErkan AlpsoyPublished in: The Journal of dermatological treatment (2021)
Our study shows that psoriasis patients using systemic immunosuppressive do not have a higher, but even lower COVID-19 risk than the general population, and treatment compliance with biological drugs is higher.